已收盤 09-21 16:00:00 美东时间
0.000
NaN.00%
LENSAR ( ($LNSR) ) has issued an update. On July 2, 2025, LENSAR, Inc. held a v...
07-03 04:17
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
06-03 04:01
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.
05-30 01:28
LENSAR ( ($LNSR) ) just unveiled an update. On March 23, 2025, LENSAR, Inc. ent...
05-23 05:12
New activity is brewing for LENSAR ( ($LNSR) ). The company has submitted a For...
05-20 05:16
NEW YORK, May 16, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the ...
05-17 06:30
LENSAR (NASDAQ:LNSR) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.21) by 1004.76 percent. This is a 1121.05 percent decrease over losses of $(0.19) per share from the
05-08 19:27
Alcon (ALC) said on Wednesday it has acquired a majority interest in Aurion Biotech, a company into developing advanced cell therapies to treat eye diseases. Aurion will continue to operate independen...
03-27 04:55
NEW YORK, March 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
03-25 00:04
Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 2025.
03-24 23:26